Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Onkovit AS
AS
Active
Org 914114829
Berglivegen 40, 9017
Tromsø
General medical practice activities
·
NACE 8621
Est. 2014 · 11 years old
1 employees
Monitor
Share
Norway
/
Companies
/
General medical practice activities
/
Onkovit AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
5M
4M
2M
1M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 4M (+33% vs 2022)
4M
+33%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
2025: 4M (0% vs 2024)
4M
0%
2025
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
4 266
3 984
3 773
3 139
2 854
Staff expenses
−2 997
−2 893
−2 960
−1 958
−1 874
EBITDA
37
−4
−193
137
51
Depreciation & amort.
−0
−11
−16
−18
−7
EBIT
37
−15
−208
120
44
Net financials
−49
−53
−46
−43
−38
Profit before tax
−12
−67
−254
77
6
Tax
−0
−0
−0
−0
−0
Net profit
−12
−67
−254
77
6
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
155
145
201
338
209
Equity
−791
−779
−712
−458
−535
Long-term debt
0
0
0
0
0
Short-term debt
946
924
913
795
744
Total debt
946
924
913
795
744
Financial ratios
5-year trend
EBITDA margin
0,9 %
This company
15,8 %
Market median
This company
Market median
94% below market
2021
2025
Equity ratio
−509,1 %
This company
38,2 %
Market median
This company
Market median
>999% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin
−0,3 %
This company
8,1 %
Market median
This company
Market median
104% below market
2021
2025
Asset turnover
27,46×
This company
1,12×
Market median
This company
Market median
>999% above market
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Onkovit AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
